Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
apolipoprotein A5 | 0.587 | 0.615 | 5.6E-10 |
|
phenotype | 0.100 | None | 1.000 | 5 | 12 | 2009 | 2019 | ||||||||
|
apolipoprotein B | 0.453 | 0.808 | 1.9E-16 |
|
phenotype | 0.100 | None | 1.000 | 6 | 7 | 2007 | 2019 | ||||||||
|
apolipoprotein C1 | 0.581 | 0.577 | 0.22 |
|
phenotype | 0.100 | None | 1.000 | 4 | 3 | 2012 | 2019 | ||||||||
|
apolipoprotein C3 | 0.531 | 0.731 | 1.0E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2019 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2012 | 2019 | ||||||||
|
amyloid beta precursor protein | 0.422 | 0.846 | 4.7E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 4 | 2012 | 2012 | ||||||||
|
Rho GTPase activating protein 5 | 0.769 | 0.192 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
arrestin beta 1 | 0.588 | 0.846 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 | 0.529 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
BRISC and BRCA1 A complex member 2 | 0.682 | 0.538 | 0.17 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
bromodomain adjacent to zinc finger domain 1B | 0.530 | 0.731 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 5 | 6 | 2008 | 2019 | ||||||||
|
BCAR1 scaffold protein, Cas family member | 0.518 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2018 | ||||||||
|
BCL3 transcription coactivator | 0.541 | 0.731 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2012 | 2012 | ||||||||
|
BCL2 interacting killer | 0.653 | 0.462 | 5.0E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
biogenesis of lysosomal organelles complex 1 subunit 3 | 0.729 | 0.385 | 4.1E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | ||||||||
|
basonuclin 2 | 0.612 | 0.615 | 0.93 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
BUD13 homolog | 0.751 | 0.538 | 2.1E-06 |
|
phenotype | 0.100 | None | 1.000 | 6 | 10 | 2008 | 2019 | ||||||||
|
chromosome 1 open reading frame 141 | 0.691 | 0.385 | 3.2E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
complement C1q C chain | 0.751 | 0.423 | 4.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
chromosome 2 open reading frame 16 | 0.890 | 0.115 | 1.3E-14 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2009 | 2012 | ||||||||
|
complement C3 | 0.445 | 0.885 | 0.90 |
|
phenotype | 0.100 | None | 1.000 | 1 | 4 | 2012 | 2012 | ||||||||
|
chromosome 5 putative open reading frame 67 | 0.890 | 0.115 | 2.2E-02 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2010 | 2019 | ||||||||
|
calcium voltage-gated channel subunit alpha1 C | 0.510 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2012 | 2012 | ||||||||
|
calcium voltage-gated channel auxiliary subunit beta 2 | 0.659 | 0.538 | 2.7E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 |